Journal article
Controversies concerning vitamin K and the newborn
Pediatrics (Evanston), Vol.112(1), pp.191-192
07/01/2003
DOI: 10.1542/peds.112.1.191
PMID: 12837888
Abstract
Prevention of early vitamin K deficiency bleeding (VKDB) of the newborn, with onset at birth to 2 weeks of age (formerly known as classic hemorrhagic disease of the newborn), by oral or parenteral administration of vitamin K is accepted practice. In contrast, late VKDB, with onset from 2 to 12 weeks of age, is most effectively prevented by parenteral administration of vitamin K. Earlier concern regarding a possible causal association between parenteral vitamin K and childhood cancer has not been substantiated. This revised statement presents updated recommendations for the use of vitamin K in the prevention of early and late VKDB. [PUBLICATION ABSTRACT]
Details
- Title: Subtitle
- Controversies concerning vitamin K and the newborn
- Creators
- Lilian BlackmonDaniel BattonEdward BellWilliam EngleCommittee on Fetus and Newborn, American Academy of Pediatrics
- Resource Type
- Journal article
- Publication Details
- Pediatrics (Evanston), Vol.112(1), pp.191-192
- Publisher
- American Academy of Pediatrics
- DOI
- 10.1542/peds.112.1.191
- PMID
- 12837888
- ISSN
- 0031-4005
- eISSN
- 1098-4275
- Language
- English
- Date published
- 07/01/2003
- Academic Unit
- Stead Family Department of Pediatrics; Neonatology
- Record Identifier
- 9984354515602771
Metrics
29 Record Views